Whittier Trust’s Intellia Therapeutics NTLA Stock Holding History

Whittier Trust’s Portfolio NTLA Stock Details NTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-750	Closed	-$8.74K	–	1551
2024 Q4	$8.74K	Sell	750 -10	-1%	-$156	﹤0.01%	1268
2024 Q3	$15.6K	Hold	760	–	–	﹤0.01%	1172
2024 Q2	$17K	Hold	760	–	–	﹤0.01%	1129
2024 Q1	$20.9K	Hold	760	–	–	﹤0.01%	1114
2023 Q4	$23.2K	Sell	760 -452	-37%	-$13K	﹤0.01%	1075
2023 Q3	$38.3K	Buy	1,212 +4	+0.3%	+$155	﹤0.01%	975
2023 Q2	$49.2K	Hold	1,208	–	–	﹤0.01%	934
2023 Q1	$45K	Hold	1,208	–	–	﹤0.01%	985
2022 Q4	$42.1K	Buy	1,208 +448	+59%	+$21.3K	﹤0.01%	996
2022 Q3	$43K	Hold	760	–	–	﹤0.01%	994
2022 Q2	$39K	Hold	760	–	–	﹤0.01%	1010
2022 Q1	$55K	Hold	760	–	–	﹤0.01%	950
2021 Q4	$90K	Buy	760 +367	+93%	+$46K	﹤0.01%	850
2021 Q3	$53K	Hold	393	–	–	﹤0.01%	918
2021 Q2	$64K	Hold	393	–	–	﹤0.01%	897
2021 Q1	$32K	Hold	393	–	–	﹤0.01%	1037
2020 Q4	$21K	Hold	393	–	–	﹤0.01%	1035
2020 Q3	$8K	Hold	393	–	–	﹤0.01%	1163
2020 Q2	$8K	Hold	393	–	–	﹤0.01%	1098
2020 Q1	$5K	Hold	393	–	–	﹤0.01%	1218
2019 Q4	$6K	Hold	393	–	–	﹤0.01%	1218
2019 Q3	$5K	Hold	393	–	–	﹤0.01%	1257
2019 Q2	$6K	Hold	393	–	–	﹤0.01%	1133
2019 Q1	$7K	Hold	393	–	–	﹤0.01%	1106
2018 Q4	$5K	Hold	393	–	–	﹤0.01%	1166
2018 Q3	$11K	Hold	393	–	–	﹤0.01%	1036
2018 Q2	$11K	Buy	+393	New	+$9.52K	﹤0.01%	1018

Other funds holding NTLA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Whittier Trust's NTLA Position: Q1 2025 in Review

Whittier Trust sold out of Intellia Therapeutics (NTLA) in Q1 2025, closing a stake of 750 shares — an estimated $8.74K sold.

Whittier Trust first reported a position in NTLA in Q2 2018 and held it in 27 quarters. The position peaked at $90K in Q4 2021. 294 funds tracked by Wall St. Rank hold NTLA as of Q1 2025.

Whittier Trust reported no remaining Intellia Therapeutics position as of Q1 2025 after selling out during the quarter.
Whittier Trust sold 750 Intellia Therapeutics shares in Q1 2025, an estimated $8.74K.
Whittier Trust first reported a position in Intellia Therapeutics in Q2 2018 and held it in 27 quarters.
Whittier Trust's Intellia Therapeutics position peaked at $90K in Q4 2021.
294 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q1 2025.

Based on Whittier Trust's 13F filing for Q1 2025, filed 2 May 2025.